The Western Cape Department of Health and Wellness has begun distributing Lenacapavir, a long-acting medication for HIV prevention, offering individuals at risk more choices and hope in the fight against HIV.

Gauteng is set to roll out Lenacapavir, a new long-acting HIV prevention injection, targeting over 56,000 individuals at high risk of HIV infection.

A twice-yearly injectable HIV prevention drug has arrived in South Africa. The rollout of the drug, lenacapavir, is underway in the country that needs it the most, about…